These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24577891)

  • 1. A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
    Li H; Zhang K; Liu LH; Ouyang Y; Bu J; Guo HB; Xiao T
    Tumour Biol; 2014 Jun; 35(6):5487-91. PubMed ID: 24577891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma: A meta-analysis of 16 studies.
    Zhou J; Liu T; Wang W
    Medicine (Baltimore); 2018 Nov; 97(44):e13051. PubMed ID: 30383677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase 9 expression and survival of patients with osteosarcoma: a meta-analysis.
    Liu Y; Wang Y; Teng Z; Chen J; Li Y; Chen Z; Li Z; Zhang Z
    Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26239566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on Li H et al. "A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma".
    Zhang Q; Li J; Liu F; Li Z
    Tumour Biol; 2015 Jan; 36(1):5-6. PubMed ID: 25416443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis.
    Bu J; Li H; Liu LH; Ouyang YR; Guo HB; Li XY; Xiao T
    Int J Clin Exp Pathol; 2014; 7(9):6091-6. PubMed ID: 25337256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.
    Chen D; Zhang YJ; Zhu KW; Wang WC
    Tumour Biol; 2013 Jun; 34(3):1895-9. PubMed ID: 23589053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.
    Wen X; Liu H; Yu K; Liu Y
    Tumour Biol; 2014 Jan; 35(1):845-8. PubMed ID: 24037915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of MMP-2 expression and prognosis in osteosarcoma patients.
    Zhang M; Zhang X
    Int J Clin Exp Pathol; 2015; 8(11):14965-70. PubMed ID: 26823829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma.
    Fu Y; Lan T; Cai H; Lu A; Yu W
    Medicine (Baltimore); 2018 May; 97(19):e0741. PubMed ID: 29742740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
    Han J; Yong B; Luo C; Tan P; Peng T; Shen J
    World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis.
    Jiao G; Ren T; Lu Q; Sun Y; Lou Z; Peng X; Liang W; Guo W
    Tumour Biol; 2013 Oct; 34(5):2489-95. PubMed ID: 23857285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
    Gu R; Sun Y
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis.
    Chen J; Sun MX; Hua YQ; Cai ZD
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1205-10. PubMed ID: 24682390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma.
    Futamura N; Nishida Y; Urakawa H; Kozawa E; Ikuta K; Hamada S; Ishiguro N
    Tumour Biol; 2014 Jun; 35(6):5159-65. PubMed ID: 24481662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of vascular endothelial growth factor as a prognostic and clinicopathological marker in osteosarcoma: a systematic review and meta-analysis.
    Zhang C; Wang L; Xiong C; Zhao R; Liang H; Luo X
    J Orthop Surg Res; 2021 Dec; 16(1):738. PubMed ID: 34963495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
    Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
    Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase 9 (MMP-9) in osteosarcoma: review and meta-analysis.
    Wang J; Shi Q; Yuan TX; Song QL; Zhang Y; Wei Q; Zhou L; Luo J; Zuo G; Tang M; He TC; Weng Y
    Clin Chim Acta; 2014 Jun; 433():225-31. PubMed ID: 24704305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis.
    Wang Y; Wei Y; Huang J; Li X; You D; Wang L; Ma X
    BMC Cancer; 2024 Aug; 24(1):1065. PubMed ID: 39210344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis.
    Guo S; Bai R; Zhao W; Wang Y; Zhao Z; Feng W
    Tumour Biol; 2014 Jan; 35(1):469-73. PubMed ID: 23959472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of matrix metalloproteinase-3 in human osteosarcoma and its association with tumor metastasis.
    Huang JF; Du WX; Chen JJ
    J BUON; 2016; 21(5):1279-1286. PubMed ID: 27837634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.